ASCENTAGE PHARMA GROUP INTERNATIONAL

AAPG · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$1,182-$568$163-$523
Dep. & Amort.$0$46$47$48
Deferred Tax$0$0$0$0
Stock-Based Comp.$26$12$9$13
Change in WC$0$87$0-$69
Other Non-Cash$1,155$666-$573$174
Operating Cash Flow$0$243-$354-$358
Investing Activities
PP&E Inv.$0-$8-$17-$12
Net Acquisitions$0-$10$0-$20
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$213-$115$119
Investing Cash Flow$0-$231-$131$87
Financing Activities
Debt Repay.$0$0-$99$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0-$2-$6
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$82$498-$81
Financing Cash Flow$0-$82$397-$87
Forex Effect$0$11$3$6
Net Chg. in Cash$0$0$952$0
Supplemental Information
Beg. Cash$0$952$0$1,390
End Cash$0$893$952$1,038
Free Cash Flow$0$235-$371-$370
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Financial Statements & Key Stats | AlphaPilot